EGFR and atherosclerosis: Pathways such as EGFR tyrosine kinase inhibitor resistance, lipid and atherosclerosis, the vascular endothelial growth factor (VEGF) signaling pathway, and the PI3K-Akt signaling pathway were closely related to the mechanism of action of J. procumbens active compounds in platelet aggregation-related diseases.